Congenital disorders of glycosylation

Gene: ALG13

Red List (low evidence)

ALG13 (ALG13, UDP-N-acetylglucosaminyltransferase subunit)
EnsemblGeneIds (GRCh38): ENSG00000101901
EnsemblGeneIds (GRCh37): ENSG00000101901
OMIM: 300776, Gene2Phenotype
ALG13 is in 9 panels

2 reviews

Sarah Leigh (Genomics England Curator)

Comment on mode of inheritance: From OMIM and Gen2Phen
Created: 12 Aug 2019, 11:48 a.m. | Last Modified: 12 Aug 2019, 11:48 a.m.
Panel Version: 1.27
Comment when marking as ready: Associated with phenotype in OMIM and as a probable Developmental Disorder Gene / G2P. At least 1 variant reported.
Created: 15 Dec 2016, 10:19 a.m.

Daniel Ungar (University of York, Department of Biology)

Green List (high evidence)

Not all ALG13 mutant patients show defects in standard glycosylation disorder testing, but this does not rule out that glycosylation is the major cause for the pathogenic phenotype in all patients.
Created: 9 Dec 2016, 12:19 p.m.

Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females

Publications

Details

Mode of Inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Red
  • UKGTN
  • Radboud University Medical Center, Nijmegen
  • Literature
  • Emory Genetics Laboratory
Phenotypes
  • Epileptic encephalopathy, early infantile, 36 300884
  • ALG13-CDG (Disorders of protein N-glycosylation)
OMIM
300776
Clinvar variants
Variants in ALG13
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

12 Aug 2019, Gel status: 1

Set mode of inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for gene: ALG13 was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

19 Dec 2016, Gel status: 1

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

Promoted to V1 19th December 2016

15 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

15 Dec 2016, Gel status: 1

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

15 Dec 2016, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for ALG13 were set to 27604308; 22492991; 25732998

1 Dec 2016, Gel status: 3

Added New Source

Sarah Leigh (Genomics England Curator)

ALG13 was added to Congenital disorders of glycosylationpanel. Source: UKGTN

1 Dec 2016, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

ALG13 was added to Congenital disorders of glycosylationpanel. Source: Radboud University Medical Center, Nijmegen

1 Dec 2016, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

ALG13 was added to Congenital disorders of glycosylationpanel. Source: Literature

1 Dec 2016, Gel status: 0

Created

Sarah Leigh (Genomics England Curator)

ALG13 was created by sleigh

1 Dec 2016, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

ALG13 was added to Congenital disorders of glycosylationpanel. Sources: Emory Genetics Laboratory